Urothelial Carcinoma Bladder Recurrent
Also known as: Recurrent Urothelial Carcinoma Bladder / Recurrent Bladder Urothelial Carcinoma / Bladder transitional cell carcinoma recurrent
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB13007 | Enfortumab vedotin | 1 | Recruiting | 1 |
DB12147 | Erdafitinib | 1 | Recruiting | 1 |
DB00062 | Albumin human | 2 | Withdrawn | 1 |
DB11595 | Atezolizumab | 2 | Active Not Recruiting | 3 |
DB12768 | BCG vaccine | 2 | Completed | 1 |
DB10343 | Bacillus calmette-guerin substrain tice live antigen | 2 | Completed | 1 |
DB08871 | Eribulin | 2 | Active Not Recruiting | 1 |
DB00530 | Erlotinib | 2 | Completed | 1 |
DB11997 | Interleukin-7 | 2 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 2 | Recruiting | 1 |
DB01229 | Paclitaxel | 2 | Withdrawn | 1 |
DB14851 | Relatlimab | 2 | Recruiting | 1 |